Advertisement

Pussy Riot to Norway in May

On 24 May, Maria Aljokhina and Nadezhda Tolokonnikova will present documentary film “Pussy vs Putin – Russian Riot Grrrls” and talk about their new project at this year’s festival.

– The filmmakers have followed us from the very beginning. They are critical in the development of our political and aesthetic expressions. This film is unique. “Pussy vs Putin” provides an objective depiction from inside. We hope everyone who supports us come and see, write the two members in an e-mail to the Festival.

Prisons and fjords

When they are in Norway, they will talk about their new project Zona Prava. They come first to Oslo where they want to visit prisons and to meet Amnesty International. They will also visit the Norwegian Festival of Literature in Lillehammer, to be held from 20 24th May, before they come to Bergen. Under the comprehensive Norway visit , they will also see the Norwegian fjords.

Pussy Riot is a Russian feminist punk rock protest group based in Moscow. Founded in August 2011, it has a variable membership of approximately 11 women ranging in age from about 20 to 33, who wear brightly colored balaclavas and use only nicknames during interviews. They stage unauthorized provocative guerrilla performances in unusual public locations, which are edited into music videos and posted on the Internet. Their lyrical themes include feminism, LGBT rights, opposition to the policies of Russian President Vladimir Putin, and links between Putin and the leadership of the Russian Orthodox Church.

On February 21, 2012, five members of the group staged a performance on the soleas of Moscow’s Cathedral of Christ the Savior. Their actions were stopped by church security officials. 

On March 3, 2012, two of the group members, Nadezhda Tolokonnikova and Maria Alyokhina, were arrested and charged with hooliganism. After nearly two years behind bars and much international outcry, the two imprisoned members of the Russian Pussy Riot were released from jail in Christmas.

A Continuing Challenge of Fake And Substandard Medicaments

Comments
- Advertisment -
Advertisement

Must Read